Therapeutic RSK1 Targeting in Myelofibrosis
type: MedicalStudy
description: Therapeutic RSK1 Targeting in Myelofibrosis
status: NOT_YET_RECRUITING
study design: INTERVENTIONAL
phase: PHASE1
start date: 2026-05-31
end date: 2028-12-31
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT07379125
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Washington University School of Medicine
study subject: Myelofibrosis
keywords: PHASE1
keywords: INTERVENTIONAL
keywords: NOT_YET_RECRUITING
keywords: Myelofibrosis

AI Analytics
type: Organization